18F-DOPA吸收图表作为同情活动的指标
Rui Wu1, Saijian Shi2, Yuanjie Huang1
1Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Frontiers in physiology
|November 5, 2025
概括
18F-DOPA PET-CT成像有效地通过显示术后脏吸收减少来衡量脏缩 (RDN) 的有效性. 这种新的方法有助于评估RDN.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管成像 - 心血管成像
- 干预心脏病学 干预心脏病学
背景情况:
- 脏缩 (RDN) 是对耐火性高血压的潜在治疗方法.
- 评估非侵入性神经切除疗法的有效性仍然是一个挑战.
研究的目的:
- 开发和验证一种使用F-DOPA微PET-CT成像评估RDN疗效的新方法.
- 为了将成像发现与同情活动的生理和分子标记者相关联.
主要方法:
- 在双边RDN之前和之后,对自发高血压大鼠 (SHRs) 和Wistar京都大鼠 (WKYs) 进行了F-DOPA微PET-CT成像.
- 脏F-DOPA吸收量被量化并在各组之间进行了比较.
- 结果通过血压监测,西部斑块和免疫组织化学验证.
主要成果:
- 双边RDN显著降低了正常功能的SHRs中的F-DOPA吸收.
- 在WKY中也观察到类似的趋势.
- F-DOPA吸收的变化与降低血压和交感神经标记物相关.
结论:
- 18F-DOPA PET-CT成像作为一种有价值的工具,用于在体内评估RDN疗效.
- 这种成像方式与同情神经活动相关,可以帮助评估临床结果.
- 需要进一步的研究来阐明脏18F-DOPA吸收减少后的分子机制.
更多相关视频
07:25Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
8.9K
13:35A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
Published on: March 1, 2018
15.3K
相关概念视频
Adrenergic Neurons: Neurotransmission
5.1K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
5.1K
Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
